Your browser doesn't support javascript.
[Annual review of venous thromboembolism in 2021].
Xu, F Y; Zhai, Z G.
  • Xu FY; Peking University China-Japan Friendship School of Clinical Medicine, Beijing 100029, China.
  • Zhai ZG; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, National Center for Respiratory Medicine Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Research Center for Respiratory Diseases, Beijing 100029, China.
Zhonghua Jie He He Hu Xi Za Zhi ; 45(6): 588-592, 2022 Jun 12.
Article in Chinese | MEDLINE | ID: covidwho-1879503
ABSTRACT
In the past year, significant progress has been made in the field of venous thromboembolism (VTE) including risk assessment and anticoagulation prevention, diagnostic strategies and model exploration, new drug development and disease management. Particularly, major breakthroughs have been made in the prevention of VTE with FXI inhibitors and the prevention of novel coronavirus pneumonia with coagulation alterations and anticoagulation interventions. Here, we reviewed the progress and achievements in the field of VTE in the past year, aiming to provide evidence and ideas for the diagnosis, treatment and future studies of VTE.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Venous Thromboembolism / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: Chinese Journal: Zhonghua Jie He He Hu Xi Za Zhi Year: 2022 Document Type: Article Affiliation country: Cma.j.cn112147-20220225-00154

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Venous Thromboembolism / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: Chinese Journal: Zhonghua Jie He He Hu Xi Za Zhi Year: 2022 Document Type: Article Affiliation country: Cma.j.cn112147-20220225-00154